Work

Mp14-19 Arv-766, a Protac Androgen Receptor (ar) Degrader, Combined With Abiraterone in Novel Hormonal Agent (nha)-naïve Metastatic Prostate Cancer: Phase 1 Cohort (part C) of a Phase 1/2 Study

Year: 2024

Type: article

Source: The Journal of Urology

DOI: 10.1097/01.ju.0001009428.69695.82.19

Authors: Neal Shore, Joshua M. Lang, Daniel M. Geynisman, Tyler F. Stewart, Xin Gao, Leonard J. Appleman, Robert Dreicer, Tanya Dorff, Elmer Berghorn, Elizabeth Duperret, Haolan Lu, Edward Chan, Benjamin Garmezy, Daniel P. Petrylak

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394803121

FWCI:

Cites:

Cited by:

Related to: 10